Starpharma Holdings
Advertisement
- Exclusive
- Coronavirus pandemic
Australian COVID nasal spray not on shop shelves amid TGA dispute
The Aussie biotech’s nasal spray is not available in Australia despite being widely sold overseas for more than a year.
- Emma Koehn
Latest
Starpharma pauses UK sales of COVID spray after regulator’s queries
The Melbourne biotech has paused sales of its coronavirus fighting product after the UK medicines watchdog wrote to its distributor questioning its promotional claims.
- Emma Koehn
Starpharma hunts for cash as it speeds up COVID nasal spray treatment
The Melbourne biotech is in a trading halt as it launches a placement for a COVID treatment it hopes to be ready by next year.
- Emma Koehn
Pandemic a catalyst for boosting commercial outcomes, says Starpharma boss
The listed biotech's boss Dr Jackie Fairley says the local sector needs to better translate research into viable remedies, as the pandemic puts the sector in the spotlight.
- Emma Koehn
Original URL: https://www.smh.com.au/topic/spl-1gh